Related references
Note: Only part of the references are listed.Activation of PPARδ up-regulates fatty acid oxidation and energy uncoupling genes of mitochondria and reduces palmitate-induced apoptosis in pancreatic β-cells
Jun Wan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms
Deepa S. De Silva et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Ligand-Activated Peroxisome Proliferator-Activated Receptor-γ Protects Against Ischemic Cerebral Infarction and Neuronal Apoptosis by 14-3-3∈ Upregulation
Jui-Sheng Wu et al.
CIRCULATION (2009)
Peroxisome Proliferator-Activated Receptor δ Regulates Extracellular Matrix and Apoptosis of Vascular Smooth Muscle Cells Through the Activation of Transforming Growth Factor-β1/Smad3
Hyo Jung Kim et al.
CIRCULATION RESEARCH (2009)
The PPAR-γ agonist rosiglitazone facilitates Akt rephosphorylation and inhibits apoptosis in cardiomyocytes during hypoxia/reoxygenation
H. Kilter et al.
DIABETES OBESITY & METABOLISM (2009)
Rosiglitazone and PPAR-γ Overexpression Protect Mitochondrial Membrane Potential and Prevent Apoptosis by Upregulating Anti-Apoptotic Bcl-2 Family Proteins
Jui-Sheng Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Peroxisome proliferator-activated receptor alpha plays a crucial role in L-carnitine anti-apoptosis effect in renal tubular cells
Hsi-Hsien Chen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and diseased
Emma Robinson et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Emerging roles of peroxisome proliferator-activated receptor-β/δ in inflammation
David Bishop-Bailey et al.
PHARMACOLOGY & THERAPEUTICS (2009)
The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development
Deborah K. Morrison
TRENDS IN CELL BIOLOGY (2009)
Prostacyclin-induced peroxisome proliferator-activated receptor-α translocation attenuates NF-κB and TNF-α activation after renal ischemia-reperfusion injury
Hsi-Hsien Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Peroxisome proliferator-activated receptor-δ agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway
Jung-Kyu Han et al.
CIRCULATION (2008)
Nonsteroidal Anti-Inflammatory Drugs Induced Endothelial Apoptosis by Perturbing Peroxisome Proliferator-Activated Receptor-δ Transcriptional Pathway
Jun-Yang Liou et al.
MOLECULAR PHARMACOLOGY (2008)
Peroxisome proliferator-activated receptor γ up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis
Karen Fuenzalida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Peroxisomal proliferator-activated receptor-α protects renal tubular cells from doxorubicin-induced apoptosis
Heng Lin et al.
MOLECULAR PHARMACOLOGY (2007)
PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells
T. -C. Ho et al.
CARDIOVASCULAR RESEARCH (2007)
Prostacyclin inhibits endothelial cell XIAP ubiquitination and degradation
Jun-Yang Liou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3ε
Jun-Yang Liou et al.
CANCER RESEARCH (2007)
Protection of endothelial survival by peroxisome proliferator-activated receptor-δ mediated 14-3-3 upregulation
Jun-Yang Liou et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
15d-Prostaglandin J2 protects brain from ischemia-reperfusion injury
TN Lin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Sorting out the roles of PPARα in energy metabolism and vascular horneostasis
P Lefebvre et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Peroxisome proliferator-activated receptor δ (PPARδ) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis
M Pesant et al.
CARDIOVASCULAR RESEARCH (2006)
Cellular and molecular biology of prostacyclin synthase
KK Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway
CY Lin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis
RG Pozner et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-δ accelerates intestinal adenoma growth
RA Gupta et al.
NATURE MEDICINE (2004)
Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation
AN Hata et al.
PHARMACOLOGY & THERAPEUTICS (2004)
PPAR-α ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G
SY Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
15-Deoxy-Δ12,14-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-γ-independent mechanism
B Hinz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
14-3-3 interacts directly with and negatively regulates pro-apoptotic bax
M Nomura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway
N Di-Poï et al.
MOLECULAR CELL (2002)
Thiazolidinedione activation of peroxisome proliferator-activated receptor γ can enhance mitochondrial potential and promote cell survival
YL Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ligands of the peroxisome proliferator-activated receptors (PPAR-γ and PPAR-α) reduce myocardial infarct size
NS Wayman et al.
FASEB JOURNAL (2002)
Peroxisome proliferator-activated receptor δ activation promotes cell survival following hypertonic stress
CM Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis
O Barbier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction
H Lin et al.
CIRCULATION (2002)
The ligands/activators for peroxisome proliferator-activated receptor alpha (PPAR alpha) and PPAR gamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells
I Inoue et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer
RA Gupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells
T Okura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Roles of PPARs in health and disease
S Kersten et al.
NATURE (2000)
Share Paper
